Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
09/14/2016
|
ARLZ |
|
PDUFA |
Cardiovascular |
None |
|
09/14/2016
|
SPPI |
|
Advisory Panel |
Oncology |
Fast Track |
|
09/15/2016
|
DVAX |
|
PDUFA |
Infectious Disease |
None |
|
09/25/2016
|
PTIE |
|
PDUFA |
Neurology |
None |
|
H2 2016
|
IDRA |
|
Phase 1/2 Results |
Oncology |
None |
|
Q3 2016
|
TNXP |
|
Phase 3 Results |
Neurology |
Special Protocol Assessment |
|
Q3 2016
|
TBRA |
|
Phase 2b Results |
Endocrine |
Fast Track |
|
H2 2016
|
ADMA |
|
PDUFA |
Autoimmune |
None |
|
Q3 2016
|
AERI |
|
Phase 3 Results |
Opthamology |
None |
|
Q3 2016
|
NVAX |
|
Phase 3 Results |
Infectious Disease |
Fast Track |
|